New advances may hold key to fight preeclampsiaOctober 16th, 2010 - 6:06 pm ICT by ANI
Washington, Oct 16 (ANI): Scientists are set to develop a potential lab test to diagnose preeclampsia-a serious complication often requires premature delivery and is sometimes fatal to both mother and fetus.
Researchers led by a team at Brown University and Women & Infants Hospital has also made a well-defined animal model of preeclampsia.
“Our model is the first pregnancy-specific animal model and our predictive assay is the first one where we can go back to the first trimester and predict problems,” said Surendra Sharma of the Brown University
Building on research linking the presence of the immune system secretion Interleukin-10 (IL-10) to a successful course of pregnancy, the researchers started experimenting with mice genetically engineered to lack IL-10.
They hypothesized that if they isolated blood serum from human patients with preeclampsia and gave a dose of it to the mice, the rodents would develop preeclampsia symptoms.
Just to be sure, the researchers gave the preeclampsia serum to mice that were not pregnant.
Nothing happened, confirming that the onset of preeclampsia symptoms in the engineered mice was a consequence of their pregnancy.
The significance of having an animal model for preeclampsia is that it will allow for experiments that can shed light on the cause of the disease and its progression, said Sharma.
After observing how preeclampsia serum caused disruption to the spiral arteries, the team reasoned that preeclampsia serum might also disrupt the formation of vasculature in the lab.
They created an in vitro culture of two key cell types involved in spiral artery development - endothelial cells and trophoblasts - and then exposed some to serum from women with normal pregnancies and some to preeclampsia serum from women taken at various stages of their pregnancies.
The researchers found that vasculature developed normally in the presence of serum from women with normal pregnancies.
But they also found that preeclampsia serum taken from women as early as 12 to 14 weeks into their pregnancies, about 10 to 12 weeks before they were diagnosed with preeclampsia, was able to disrupt vascular formation.
“The idea is that we can predict preeclampsia ahead of time and women can be treated,” added Sharma.
The findings were reported in The American Journal of Pathology. (ANI)
- Warring placenta, uterus trigger preeclampsia - Oct 11, 2011
- Clue to early diagnosis of pregnancy-related disease - May 16, 2012
- Promising novel diagnostic biomarker for ectopic pregnancies identified - Nov 05, 2010
- Enzyme may explain preeclampsia symptoms in pregnant women - Jan 05, 2011
- Simple urine test to diagnose preeclampsia - Feb 05, 2010
- Early urinary protein test during pregnancy predicts later pre-eclampsia - Nov 25, 2010
- Pregnancy outcome linked to immune system genes - Oct 26, 2010
- Urine test can predict fatal condition in pregnant women - Nov 13, 2011
- Life-saving test developed for pregnant women - Dec 24, 2010
- Genetic changes that may predispose women to pre-eclampsia found - Mar 23, 2011
- New study focuses on cause of celiac disease - Feb 10, 2011
- Eating chocolate halves life-threatening risks during pregnancy - Jul 09, 2010
- Gene that controls immune system linked to preeclampsia - Feb 15, 2011
- Soon, simple blood test to predict preeclampsia in early pregnancy - Sep 14, 2010
- Naturally occuring protein reverses brain damage caused by meningitis - Jun 11, 2010
Tags: animal model, arteries, blood serum, brown university, disruption, endothelial cells, fetus, first trimester, human patients, infants hospital, interleukin 10, lab test, predictive assay, preeclampsia symptoms, pregnancies, premature delivery, rodents, secretion, vasculature, vitro